AbCellera Biologics Inc. ABCL Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s other operating expenses?
- AbCellera Biologics Inc. (ABCL) reported other operating expenses of $65.83M in Q1 2026.
- How has AbCellera Biologics Inc.'s other operating expenses changed year-over-year?
- AbCellera Biologics Inc.'s other operating expenses decreased by 1.6% year-over-year, from $66.9M to $65.83M.
- What is the long-term trend for AbCellera Biologics Inc.'s other operating expenses?
- Over 4 years (2021 to 2025), AbCellera Biologics Inc.'s other operating expenses has grown at a 14.4% compound annual growth rate (CAGR), from $170.73M to $292.23M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.